Rosetta Genomics Posts $2.2M Net Loss for Q3

Nov 08, 2007

NEW YORK (GenomeWeb News) – Rosetta Genomics today posted a net loss of $2.2 million, flat with last year’s third-quarter net loss, with no revenue reported for the three-month period ended Sept. 30.

The firm’s R&D expenses also were flat with the comparable period last year at $1.4 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Push for Predictive Genetic Tests

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

Gene-Editing Registry Proposed

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Sneaking Out of the Lab

Vox writes that lab mishaps involving pathogens are quite common.

This Week in Genome Biology

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.

Menu